StonvexLoading…
StonvexStonvexStonvexCore line items from CMCSA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $123.71B | $123.73B | $121.57B | $121.43B |
Operating Income | $20.67B | $23.30B | $23.31B | $14.04B |
Net Income | $20.00B | $16.19B | $15.39B | $5.37B |
EPS (Diluted) | $5.39 | $4.14 | $3.71 | $1.21 |
Total Assets | $272.63B | $266.21B | $264.81B | $257.27B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.48B | $7.32B | $6.21B | $4.75B |
Free Cash Flow OCF − CapEx | $21.89B | $15.49B | $16.26B | $15.79B |
Shares Outstanding | 3.71B | 3.91B | 4.15B | 4.43B |